JPRN-UMIN000025796招募中未知
Prospective study on Pharmacodynamics, the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with immune-checkpoint inhibitor. - Pharmacodynamic analysis and the mechanism of immune-related adverse events in immune-checkpoint inhibitor.
Department of Internal Medicine,Division of Medical Oncology, Showa University School of Medicine.0 个研究点目标入组 80 人开始时间: 2017年1月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of severe hypersensitivity to drugs used in this study. (2) Within 14 days administer other antineoplastic agent before treatment of immune checkpoint inhibitors. (3) Active infection. (4) HBs antigen, HCV antibody and HIV antibody is positive. (5) Pregnacy or patient's hope to be pregnant. (6) An inappropriate case judged by doctor in charge.
研究者
相似试验
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-CZAbbott GmbH & Co. KG100
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-DEAbbVie Deutschland GmbH & Co. KG100
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.Rheumatoid ArthritisEUCTR2012-000535-36-PLAbbott GmbH & Co. KG100
已完成
不适用
A study to investigate the pharmacodynamics, safety and tolerability of cutaneous capsaicin in healthy adult subjects.Small fibre neuropathy10034606NL-OMON37233Centre for Human Drug Research12
尚未招募
3 期
To evaluate the efficacy of guduchayadi yog in the management of dislipidemiaCTRI/2024/06/069147Post Graduate Institute of Ayurveda DSRRAU Jodhpur